Join
Live feed
·
INSIDERFilingvia Quantisnow
Inovio Pharmaceuticals Inc. logo

Chief Executive Officer Shea Jacqueline Elizabeth converted options into 28,296 shares and covered exercise/tax liability with 12,306 shares, increasing direct ownership by 17% to 111,021 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.
INO· Inovio Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INO (Inovio Pharmaceuticals Inc.) and more on Quantisnow.

Chief Executive Officer Shea Jacqueline Elizabeth converted options into 28,296 shares and covered exercise/tax liability with 12,306 shares, increasing direct ownership by 17% to 111,021 units (SEC Form 4) to satisfy withholding obligation | Quantisnow